Advisory Committee on the Medical Uses of Isotopes: Meeting Notice, 70955 [2010-29211]

Download as PDF Federal Register / Vol. 75, No. 223 / Friday, November 19, 2010 / Notices requirements as described in 10 CFR 73.55 and reflected in its current NRCapproved physical security program. By March 15, 2012, CR–3 physical security system will be in full compliance with all of the regulatory requirements of 10 CFR 73.55, as published on March 27, 2009. srobinson on DSKHWCL6B1PROD with NOTICES 4.0 Conclusion for Part 73 Schedule Exemption Request The NRC staff has reviewed the licensee’s submittals and concludes that the licensee has provided adequate justification for its request for an extension of the previously authorized implementation dates from November 15 and December 15, 2010, with regard to four specified requirements of 10 CFR 73.55, to December 15, 2011, and March 15, 2012, respectively. This conclusion is based on the NRC staff’s determination that the licensee has made a good faith effort to meet the requirements in a timely manner, has sufficiently described the reason for the unanticipated delays, and has provided an updated detailed schedule with adequate justification to the additional time requested for the extension. The long-term benefits that will be realized when the security systems upgrade is complete justify extending the full compliance date with regard to the specific requirements of 10 CFR 73.55 for this particular licensee. The security measures that CR–3 needs additional time to implement are new requirements imposed by amendments to 10 CFR 73.55, as published on March 27, 2009, and are in addition to those required by the security orders issued in response to the events of September 11, 2001. Accordingly, an exemption from the March 31, 2010, implementation date is authorized by law and will not endanger life or property or the common defense and security, and the Commission hereby grants the requested exemption. As per the licensee’s request and the NRC’s regulatory authority to grant an exemption to the March 31, 2010, implementation date for the four items specified in Attachment 1 of the FPC letter dated September 8, 2010, the licensee is required to implement two items by December 15, 2011, and to implement the remaining two items by March 15, 2012. The licensee is required to be in full compliance with 10 CFR 73.55 by March 15, 2012. In achieving compliance, the licensee is reminded that it is responsible for determining the appropriate licensing mechanism (i.e., 10 CFR 50.54(p) or 10 CFR 50.90) for incorporation of all necessary changes to its security plans. VerDate Mar<15>2010 17:02 Nov 18, 2010 Jkt 223001 In accordance with 10 CFR 51.32, ‘‘Finding of no significant impact,’’ the Commission has previously determined that the granting of this exemption will not have a significant effect on the quality of the human environment (75 FR 69710 dated November 15, 2010). This exemption is effective upon issuance. Dated at Rockville, Maryland, this 15th day of November 2010. For the Nuclear Regulatory Commission. Joseph G. Giitter, Director, Division of Operating Reactor Licensing, Office of Nuclear Reactor Regulation. [FR Doc. 2010–29212 Filed 11–18–10; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION Advisory Committee on the Medical Uses of Isotopes: Meeting Notice U.S. Nuclear Regulatory Commission. ACTION: Notice of meeting. AGENCY: The U.S. Nuclear Regulatory Commission will convene a teleconference meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on December 13, 2010, to discuss: (1) Patient release following iodine-131 therapy; (2) rulemaking and implementation guidance for physical protection of byproduct material; and (3) the impacts of the draft safety culture policy statement for medical licensees. A copy of the agenda for the meeting will be available at http://www.nrc.gov/readingrm/doc-collections/acmui/agenda or by contacting Ms. Ashley Cockerham using the information below. DATES: The teleconference meeting will be held on Monday, December 13, 2010, from 1 p.m. to 4 p.m. Eastern Standard Time. Public Participation: Any member of the public who wishes to participate in the teleconference discussion should contact Ms. Cockerham using the contact information below. Contact Information: Ashley M. Cockerham, e-mail: ashley.cockerham@nrc.gov, telephone: (240) 888–7129. SUMMARY: Conduct of the Meeting Leon S. Malmud, M.D., will chair the meeting. Dr. Malmud will conduct the meeting in a manner that will facilitate the orderly conduct of business. The following procedures apply to public participation in the meeting: PO 00000 Frm 00061 Fmt 4703 Sfmt 4703 70955 1. Persons who wish to provide a written statement should submit an electronic copy to Ms. Cockerham at the contact information listed above. All submittals must be received by December 8, 2010, and must pertain to the topic on the agenda for the meeting. 2. Questions and comments from members of the public will be permitted during the meeting, at the discretion of the Chairman. 3. The transcript will be available on the ACMUI’s Web site (http:// www.nrc.gov/reading-rm/doccollections/acmui/tr/) on or about January 13, 2011. A meeting summary will be available on or about January 27, 2011. This meeting will be held in accordance with the Atomic Energy Act of 1954, as amended (primarily Section 161a); the Federal Advisory Committee Act (5 U.S.C. App); and the Commission’s regulations in Title 10, U.S. Code of Federal Regulations, Part 7. Dated: November 15, 2010. Andrew L. Bates, Advisory Committee Management Officer. [FR Doc. 2010–29211 Filed 11–18–10; 8:45 am] BILLING CODE 7590–01–P PENSION BENEFIT GUARANTY CORPORATION Proposed Submission of Information Collection for OMB Review; Comment Request; Liability for Termination of Single-Employer Plans Pension Benefit Guaranty Corporation. ACTION: Notice of intention to request extension of OMB approval. AGENCY: The Pension Benefit Guaranty Corporation (PBGC) intends to request that the Office of Management and Budget (OMB) extend approval, under the Paperwork Reduction Act, of a collection of information contained in its regulation on Liability for Termination of Single-Employer Plans, 29 CFR Part 4062 (OMB control number 1212–0017; expires March 31, 2011). This notice informs the public of PBGC’s intent and solicits public comment on the collection of information. DATES: Comments should be submitted by January 18, 2011. ADDRESSES: Comments may be submitted by any of the following methods: Federal eRulemaking Portal: http://www.regulations.gov. Follow the Web site instructions for submitting comments. SUMMARY: E:\FR\FM\19NON1.SGM 19NON1

Agencies

[Federal Register Volume 75, Number 223 (Friday, November 19, 2010)]
[Notices]
[Page 70955]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-29211]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes: Meeting 
Notice

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission will convene a 
teleconference meeting of the Advisory Committee on the Medical Uses of 
Isotopes (ACMUI) on December 13, 2010, to discuss: (1) Patient release 
following iodine-131 therapy; (2) rulemaking and implementation 
guidance for physical protection of byproduct material; and (3) the 
impacts of the draft safety culture policy statement for medical 
licensees. A copy of the agenda for the meeting will be available at 
http:[sol][sol]www.nrc.gov/reading-rm/doc-collections/acmui/agenda or 
by contacting Ms. Ashley Cockerham using the information below.

DATES: The teleconference meeting will be held on Monday, December 13, 
2010, from 1 p.m. to 4 p.m. Eastern Standard Time.
    Public Participation: Any member of the public who wishes to 
participate in the teleconference discussion should contact Ms. 
Cockerham using the contact information below.
    Contact Information: Ashley M. Cockerham, e-mail: 
ashley.cockerham@nrc.gov, telephone: (240) 888-7129.

Conduct of the Meeting

    Leon S. Malmud, M.D., will chair the meeting. Dr. Malmud will 
conduct the meeting in a manner that will facilitate the orderly 
conduct of business. The following procedures apply to public 
participation in the meeting:
    1. Persons who wish to provide a written statement should submit an 
electronic copy to Ms. Cockerham at the contact information listed 
above. All submittals must be received by December 8, 2010, and must 
pertain to the topic on the agenda for the meeting.
    2. Questions and comments from members of the public will be 
permitted during the meeting, at the discretion of the Chairman.
    3. The transcript will be available on the ACMUI's Web site 
(http:[sol][sol] www.nrc.gov/reading-rm/doc-collections/acmui/tr/) on 
or about January 13, 2011. A meeting summary will be available on or 
about January 27, 2011.
    This meeting will be held in accordance with the Atomic Energy Act 
of 1954, as amended (primarily Section 161a); the Federal Advisory 
Committee Act (5 U.S.C. App); and the Commission's regulations in Title 
10, U.S. Code of Federal Regulations, Part 7.

    Dated: November 15, 2010.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. 2010-29211 Filed 11-18-10; 8:45 am]
BILLING CODE 7590-01-P